General Questions

1.Where do shares of Geron trade and what is the ticker symbol?
2.When was Geron incorporated?
3.What is Geron's fiscal year-end?
4.Do you anticipate paying a dividend?
5.Does Geron have a DRIP (Dividend Reinvestment Program)?
6.Can I purchase or sell my shares directly through Geron?
7.I have lost my stock certificates and my broker cannot assist me. Who do I talk with to resolve this problem?
8.What do I do if my address has changed?
9.How do I get an investor packet?
10.Who can I contact if I have questions or need more information?
11.Who can I contact if I am a member of the media?
12.Can I be added to Geron’s mailing list?

Clinical Pipeline

13.What clinical trials are underway at Geron?
14.Where are the trials being conducted?
15.How can I learn more about Geron’s clinical trials?
16.Are any of these programs partnered?
17.What happened to the stem cell programs?
1.Where do shares of Geron trade and what is the ticker symbol?
 Geron common stock trades on the Nasdaq Global Select Market under the ticker symbol GERN.

2.When was Geron incorporated?
 Geron was incorporated in Delaware in November 1990.

3.What is Geron's fiscal year-end?
 Geron is on a calendar year-end schedule.

4.Do you anticipate paying a dividend?
 The company has not paid any dividends to its stockholders since its inception and does not plan to pay cash dividends in the foreseeable future.

5.Does Geron have a DRIP (Dividend Reinvestment Program)?
 No, Geron has not paid and does not intend to pay dividends in the foreseeable future and therefore does not have a dividend reinvestment program.

6.Can I purchase or sell my shares directly through Geron?
 No, Geron does not have a direct stock purchase program. You will need to contact your broker or purchase shares through an online stock transaction service.

7.I have lost my stock certificates and my broker cannot assist me. Who do I talk with to resolve this problem?
 

Computershare
250 Royall Street
Canton, MA 02021
Tel: 1-800-962-4284
Website: www.computershare.com/investor
Shareholder online inquiries: www-us.computershare.com/investor/Contact


8.What do I do if my address has changed?
  If your shares are held in your name, you may contact Computershare Trust Company as indicated above. If your shares are held in Street name, you must contact your broker to update your address.

9.How do I get an investor packet?
 Please click here to request an investor packet.

10.Who can I contact if I have questions or need more information?
 Please contact Investor Relations via email at investor@geron.com or at 650-473-7765.

11.Who can I contact if I am a member of the media?
 Please contact Media Relations via email at media@geron.com or at 650-473-7765.

12.Can I be added to Geron’s mailing list?
 We do not maintain a postal mailing list for materials. However, if you would like to join our email distribution list for press releases, please send your name and email address to investor@geron.com.

13.What clinical trials are underway at Geron?
 Please visit our clinical trials pages for information on our clinical trials.

14.Where are the trials being conducted?
 Please visit our clinical trials pages for information on our clinical trials.

15.How can I learn more about Geron’s clinical trials?
 Please visit our clinical trials pages for information on our clinical trials.

16.Are any of these programs partnered?
 Imetelstat is partnered with Janssen Biotech Inc.

17.What happened to the stem cell programs?
 Geron is no longer funding development of the stem cell programs. On October 1, 2013, Geron closed the transaction to divest its human embryonic stem cell assets and autologous cellular immunotherapy program to Asterias Biotherapeutics, Inc. In connection with the divestiture, Geron received 6,537,779 shares of Asterias Series A common stock. On August 15, 2014, Geron completed the distribution of the Asterias Series A common stock to eligible Geron stockholders. Click here for more information.



RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | Financial Tear Sheet Financial Tear Sheet
Close
Form content here please :)